Invention Grant
- Patent Title: Methods of assessing a risk of developing necrotizing meningoencephalitis
-
Application No.: US16167463Application Date: 2018-10-22
-
Publication No.: US10770183B2Publication Date: 2020-09-08
- Inventor: Matthew Huentelman , Scott Schatzberg , Renee Barber
- Applicant: The Translational Genomics Research Institute , University of Georgia Research Foundation, Inc.
- Applicant Address: US AZ Phoenix US GA Athens
- Assignee: The Translational Genomics Research Institute,University of Georgia Research Foundation, Inc.
- Current Assignee: The Translational Genomics Research Institute,University of Georgia Research Foundation, Inc.
- Current Assignee Address: US AZ Phoenix US GA Athens
- Agency: The Noblitt Group, PLLC
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12Q1/68 ; G16H50/30 ; C12Q1/6883 ; A01K67/02
Abstract:
The present invention provides method of classifying a subject into a necrotizing meningoencephalitis (NME) disease risk group. The method may include assessing the presence of one or more marker (e.g., SNPs or risk loci) in a sample from the subject. For example, detection of the presence of one or more markers that are associated with an increased risk of NME can indicate that the subject should be classified into a risk group.
Public/Granted literature
- US20190051418A1 METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS Public/Granted day:2019-02-14
Information query
